Dr. Muredach Reilly Appointed Director-Designate of the Irving Institute for Clinical and Translational Research

Columbia University Medical Center executive leadership announces the appointment of Muredach P. Reilly, MBBCh, as director-designate of the Irving Institute for Clinical and Translational Research (CTSA), effective Feb. 1, 2016. After a year of transition, Dr. Reilly will succeed Henry N. Ginsberg, MD, as director of the CTSA, effective Jan. 1, 2017. Pending approval by Columbia Trustees, Dr. Reilly will become the Herbert and Florence Irving Professor of Medicine, an endowed chair traditionally occupied by the Irving Institute director.

Dr. Reilly joins us from the University of Pennsylvania, where he is professor of medicine and pharmacology, associate director of the school’s cardiovascular fellowship program, and an attending cardiologist at the Hospital of the University of Pennsylvania.

As a cardiovascular physician-scientist, Dr. Reilly is internationally known for multidisciplinary translational, genomic, and biomarker research on heart and metabolic diseases. He leads an NIH-funded Penn Cardiovascular Institute group focused on large-scale collaborations to identify and understand the function of new genes for heart disease.

He has received numerous honors, including the William Osler Patient Oriented Research Award from Penn Medicine and a special recognition award from the American Heart Association. He is a member of the American Society for Clinical Investigation and the American College of Cardiology and a fellow of Ireland’s Royal College of Physicians.

Dr. Reilly graduated from University College in Dublin, Ireland, where he received degrees in medicine (surgery) and pharmacology. He received a master of science degree in clinical epidemiology from the University of Pennsylvania in 2003 and has been on the university’s faculty since then.

Please join us in thanking Dr. Ginsberg for 20 years of exemplary leadership. During his tenure, Dr. Ginsberg oversaw a center that evolved from the Irving Center for Clinical Research into the Irving Institute for Clinical and Translational Research in 2006 when Columbia successfully competed for one of the first NIH CTSA—Clinical and Translational Science Awards—grants. The grant was renewed in 2011 for another five years, a recognition of success during the first five years of the program. The Irving Institute has truly become an academic and intellectual hub for preeminent clinical and translational research investigators under Dr. Ginsberg’s direction. After the leadership transition on Jan. 1, 2017, Dr. Ginsberg will remain active in CTSA activities as a co-director of the Irving Institute and continue his own active research program on the faculty at Columbia.

Please join us in congratulating and welcoming Dr. Reilly and thanking Dr. Ginsberg for his remarkable service.